We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI Platform Analyzes Data from Prostate Imaging, Biopsies and Pathology to Identify Tumor Location

By MedImaging International staff writers
Posted on 01 May 2023
Print article
The Unfold AI prostate cancer management platform enables more personalized and precise treatments (Photo courtesy of Avenda Health)
The Unfold AI prostate cancer management platform enables more personalized and precise treatments (Photo courtesy of Avenda Health)

One in eight men will develop prostate cancer during their lifetime. Current treatments often involve treating the entire prostate due to the limitations of MRI technology in identifying the full extent of tumors and cancer growth. This approach results in nearly 50% of patients experiencing a loss of sexual or urinary function. Now, an FDA-approved prostate cancer management platform combines patient-specific data from prostate imaging, biopsies, and pathology into deep-learning algorithms to create a personalized cancer estimation map. The 3D, AI-generated map helps physicians visualize the location of the cancer for treatment decision-making and intervention planning.

Avenda Health’s (Santa Monica, CA, USA) Unfold AI is an AI-powered cancer management platform that utilizes a patient's diagnostic data to determine the extent of the disease and create a cancer probability map with optimal treatment margins. Unlike existing AI products for prostate cancer that primarily aid in diagnosis, Unfold AI targets urologists to assist in deciding the best treatment strategy based on each patient's specific tumor after diagnosis. After a patient undergoes an MRI and biopsy, their data is uploaded into Unfold AI, and a physician verifies the information. The platform then generates a 3D cancer estimation map, which can guide physicians in making treatment decisions and, if necessary, create a virtual treatment plan.

Current standard care for prostate cancer includes surgery, radiation, or annual biopsies for monitoring. Cancer is treated as a whole-gland disease, despite prostate cancer being extremely localized. However, these treatments can harm structures vital to sexual and urinary function, and some patients may require additional therapy within five years. Unfold AI helps urologists determine the most suitable course of action by providing a visual representation of the likely extent of the disease and the margin for targeted therapy, which is not achievable through standard care.

Avenda validated Unfold AI's algorithms by comparing the cancer estimation maps to surgical pathology slides and by having physicians assess cases using both standard care and Unfold AI. The platform's algorithms were trained on hundreds of thousands of diagnostic patient data points and validated using held-out datasets from separate institutions. Clinical studies have shown that Unfold AI improved urologists' sensitivity in identifying the tumor's extent to over 98%. In clinical trials, guidance from the platform led to changes in treatment recommendations in 28% of cases, often towards more localized treatments. Unfold AI allows for multiple treatment options, including active surveillance, whole-gland treatments, and soft tissue laser ablation.

"Our mission at Avenda Health is to create a better quality of life for prostate cancer patients and to give urologists a clearer view of the cancer so we can better treat our patients. Unfold AI will improve clinical care and decision-making," said Dr. Leonard Marks, co-founder and Chief Medical Officer of Avenda Health.

New
Gold Supplier
Conductive Gel
Tensive
New
Digital Chest and Bone Room
Atlas HC2
New
Full-Body Fan-Beam System
Primus DXA
New
Mobile DR System
Compact

Print article
FIME - Informa

Channels

Radiography

view channel
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of... Read more

MRI

view channel
Image: Ezra Flash AI has received 510(k) FDA clearance, enabling roll out of the world’s first 30-minute full body MRI (Photo courtesy of Ezra)

World's First 30 Minute Full Body MRI Scan Offers Fast, Accurate and Affordable Cancer Diagnosis

A cutting-edge artificial intelligence (AI) solution enhances MR image quality, paving the way for a reduction in scan time and consequently, the cost of MRI procedures. This innovation now makes it feasible... Read more

Ultrasound

view channel
Image: Attaching microbubbles to macrophages can create high-resolution and sensitive tracking images useful for disease diagnosis (Photo courtesy of Georgia Institute of Technology)

Ultrasound Can Image Immune Cells Enhanced With Microbubbles to Diagnose Early Stage Cancer

Macrophages, a type of white blood cell, protect the human body by surrounding and consuming foreign particles such as bacteria, viruses, and dead cells. Notably, these immune cells tend to gather within... Read more

Nuclear Medicine

view channel
Image: New imaging method offers potential for diagnosing, staging, and treating multiple types of cancer (Photo courtesy of SNMMI)

New Imaging Method Superior for Diagnosing Multiple Types of Cancer

Cancer-associated fibroblasts play a significant role in tumor development, migration, and progression. A subset of these fibroblasts expresses fibroblast activation protein (FAP), a protein prominently... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.